Yanling Liu
31 Ji'nan Road
Shengli, China
Shengli, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
SNRPD2-mediated regulation of DDX39B splicing promotes endometrial cancer progression by suppressing the activation of CTSC cryptic exons.
Journal: Cell death & disease
Published: July 17, 2025
Spliceosomal GTPase EFTUD2 mediates DDX41 intron retention to promote the malignant progression of ovarian cancer.
Journal: British journal of cancer
Published: January 02, 2025
Role of KLF5 in enhancing ovarian cancer stemness and PARPi resistance: mechanisms and therapeutic targeting.
Journal: Journal of translational medicine
Published: November 30, 2024
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron.
Journal: Experimental & molecular medicine
Published: July 15, 2024
Long non‑coding RNA OIP5‑AS1 facilitates the progression of ovarian cancer via the miR‑128‑3p/CCNG1 axis.
Journal: Molecular medicine reports
Published: August 06, 2020
Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein.
Journal: Cell discovery
Published: June 28, 2017
Valeriana jatamansi constituent IVHD-valtrate as a novel therapeutic agent to human ovarian cancer: in vitro and in vivo activities and mechanisms.
Journal: Current cancer drug targets
Published: November 07, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026